BHST vs LIN

For growth investors, BioHarvest Sciences Inc.

Common Stock (BHST) is the stronger pick with 98. 8% revenue growth year-over-year, versus 3. 0% for Linde plc (LIN). Linde plc (LIN) offers the better valuation at 34. 4x trailing P/E (28. 1x forward), making it the more compelling value choice. Analysts rate BioHarvest Sciences Inc. Common Stock (BHST) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Linde plc (LIN) delivered a total return of +78.

1%, compared to -16. 0% for BioHarvest Sciences Inc. Common Stock (BHST). Over 10 years, the gap is even starker: LIN returned +376. 9% versus BHST's -16. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Linde plc (LIN) is the lower-risk stock at 0.

24β versus BioHarvest Sciences Inc. Common Stock's 1. 05β — meaning BHST is approximately 339% more volatile than LIN relative to the S&P 500. On balance sheet safety, Linde plc (LIN) carries a lower debt/equity ratio of 68% versus 10% for BioHarvest Sciences Inc. Common Stock — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), BioHarvest Sciences Inc.

Common Stock (BHST) is pulling ahead at 98. 8% versus 3. 0% for Linde plc (LIN). On earnings-per-share growth, the picture is similar: BioHarvest Sciences Inc. Common Stock grew EPS 14. 0% year-over-year, compared to 7. 1% for Linde plc. Over a 3-year CAGR, BHST leads at 128. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Linde plc (LIN) is the more profitable company, earning 20.

3% net margin versus -51. 3% for BioHarvest Sciences Inc. Common Stock — meaning it keeps 20. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LIN leads at 26. 3% versus -27. 7% for BHST. At the gross margin level — before operating expenses — BHST leads at 55. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

Analyst consensus price targets imply the most upside for BHST: 138.

1% to $10. 00.

In this comparison, LIN (1.

2% yield) pays a dividend. BHST does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Linde plc (LIN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

24), 1. 2% yield, +376. 9% 10Y return). Both have compounded well over 10 years (LIN: +376. 9%, BHST: -16. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: BHST is a small-cap high-growth stock; LIN is a large-cap quality compounder stock. LIN pays a dividend while BHST does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.